Scinai Immunotherapeutics : Announces Receipt of Nasdaq Delisting Notification and Appeal
The Board has Approved a Ratio Change of the ADSs to Non-traded Ordinary Shares Designed to Regain Compliance JERUSALEM, ISRAEL -May 6th, 2024 - Scinai...
Stay updated with breaking news from Ratio Change. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Board has Approved a Ratio Change of the ADSs to Non-traded Ordinary Shares Designed to Regain Compliance JERUSALEM, ISRAEL -May 6th, 2024 - Scinai...
Biophytis / Key word(s): Miscellaneous Biophytis announces ratio change under its American Depositary Receipt (“ADR...
COPENHAGEN, Denmark, Jan. 22, 2024 -- Evaxion Biotech A/S , a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that the Company’s...
MELBOURNE, Australia, Dec. 12, 2023 -- Genetic Technologies Limited , a global leader in genomics-based tests in health, wellness and serious disease, announced today its plans to effect: a share...
Net Margin to Shareholders Improved to -10.8% for Third Quarter 2023